EUVIMEDOpdag EUVIMED
Crossref

Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System

Tung S Tran iD, Duc V Le, Jena C Jacobs, Trang M Nguyen, David A Wetter, Giang H Nguyen

International Journal of Dermatology · 2026-04 · 65 (4) · 825-827

DOI: 10.1111/ijd.70082 ↗

At a glance

Journal article in International Journal of Dermatology, published online on 2025-09-24. Written by Tung S Tran and 5 co-authors. Institution: Hanoi Medical University, Hanoi, Vietnam. Cited 3 times so far (Crossref); 4 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The authors declare no conflicts of interest. Data supporting this study are available upon reasonable request to the corresponding author.

Subjects

Author keywords

FAERS databaseadverse eventsanti‐IL‐17A/Fbimekizumabpharmacovigilance study

Authors and institutions

  • Hanoi Medical University, Hanoi, Vietnam.
  • National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
  • Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bassett Medical Center, Cooperstown, New York, USA.

ORCID profiles: Tung S Tran

Cite

APA

Tran, T. S., Le, D. V., Jacobs, J. C., Nguyen, T. M., Wetter, D. A., & Nguyen, G. H. (2026). Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System. International Journal of Dermatology, 65(4), 825-827. https://doi.org/10.1111/ijd.70082

Vancouver

Tran TS, Le DV, Jacobs JC, Nguyen TM, Wetter DA, Nguyen GH. Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System. International Journal of Dermatology. 2026;65(4):825-827. doi:10.1111/ijd.70082

BibTeX
@article{Tran2026,
  author = {Tran, Tung S and Le, Duc V and Jacobs, Jena C and Nguyen, Trang M and Wetter, David A and Nguyen, Giang H},
  title = {Post‐Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System},
  journal = {International Journal of Dermatology},
  year = {2026},
  volume = {65},
  number = {4},
  pages = {825--827},
  doi = {10.1111/ijd.70082}
}
Start for free →